Q13546 (RIPK1_HUMAN) Homo sapiens (Human)
Receptor-interacting serine/threonine-protein kinase 1 UniProtKBInterProSTRINGInteractive Modelling
671 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
23 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| SSNMR Structure of the Human RIP1/RIP3 Necrosome |
Heteromer Q9Y572; | |||||
| Assess | ||||||
| VHL recognizes hydroxyproline in RIPK1 |
Heteromer P40337; Q15369; Q15370; | |||||
| Assess | ||||||
| Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor | homo-2-mer | 2×3IF; | ||||
| Assess | ||||||
| Crystal structure of human RIPK1 kinase domain in complex with compound RI-962 | homo-2-mer | 2×3CI; 7×IOD; | ||||
| Assess | ||||||
| Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor | homo-2-mer | 2×3IU; | ||||
| Assess | ||||||
| Crystal structure of human RIPK1 kinase domain in complex with compound SKLB923 | homo-2-mer | 2×IOD; 2×GO4; | ||||
| Assess | ||||||
| Rip1 Kinase ( flag 1-294, C34A, C127A, C233A, C240A) with GSK772 | homo-2-mer | 2×7MJ; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF RIP1 KINASE BOUND TO INHIBITOR | homo-2-mer | 2×EJY; | ||||
| Assess | ||||||
| X-ray structure of Receptor Interacting Protein 1 (RIP1)kinase domain with a 1-aminoisoquinoline in… | monomer | 1×MG; 1×Q1A; | ||||
| Assess | ||||||
| The RIPK1 kinase domain in complex with QY7-2B compound | monomer | 1×O4U; | ||||
| Assess | ||||||
| Crystal structure of RIP1 kinase in complex with necrostatin-4 | monomer | 1×1HX; 5×IOD; | ||||
| Assess | ||||||
| Structure of human RIPK1 kinase domain in complex with compound 11 | monomer | 1×L4Y; | ||||
| Assess | ||||||
| Structure of human RIPK1 kinase domain in complex with GNE684 | monomer | 1×L8D; 3×IOD; | ||||
| Assess | ||||||
| Crystal structure of RIP1 kinase in complex with necrostatin-1 analog | monomer | 5×IOD; 1×NA; 1×RCM; | ||||
| Assess | ||||||
| Structure based design of RIP1 kinase inhibitors | monomer | 1×EJP; | ||||
| Assess | ||||||
| Crystal structure of RIP1 kinase in complex with a pyrrolidine | monomer | 1×M5J; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of RIP1 kinase in complex with necrostatin-3 analog | monomer | 1×1HW; | ||||
| Assess | ||||||
| Crystal structure of RIP1 kinase in complex with GSK3145095 | monomer | 1×K8K; | ||||
| Assess | ||||||
| Crystal structure of RIP1 kinase in complex with GSK547 | monomer | 1×G4W; | ||||
| Assess | ||||||
| Crystal structure of RIP1 kinase in complex with DHP77 | monomer | 1×JSW; | ||||
| Assess | ||||||
| Crystal structure of RIP1 kinase with a benzo[b][1,4]oxazepin-4-one | monomer | 1×65U; | ||||
| Assess | ||||||
| Crystal structure of RIPK1 death domain GlcNAcylated by EPEC effector NleB | monomer | 1×NAG; 2×SO4; | ||||
| Assess | ||||||
| Amyloid core of RIP1 | monomer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4neu.1.A | monomer | 0.73 | 1×MG; 1×Q1A; | 100.00 | ||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4neu.1.A | monomer | 0.65 | 1×MG; | 92.09 | |
| Assess | ||||||